Found: 32
Select item for more details and to access through your institution.
The insulin/IGF system in colorectal cancer development and resistance to therapy.
- Published in:
- Frontiers in Oncology, 2015, p. 1, doi. 10.3389/fonc.2015.00230
- By:
- Publication type:
- Article
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36922-1
- By:
- Publication type:
- Article
Opportunities and Challenges of Liquid Biopsy in Thyroid Cancer.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 14, p. 7707, doi. 10.3390/ijms22147707
- By:
- Publication type:
- Article
Molecular Pathogenesis and Treatment Perspectives for Hypereosinophilia and Hypereosinophilic Syndromes.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 2, p. 486, doi. 10.3390/ijms22020486
- By:
- Publication type:
- Article
Activation of the IGF Axis in Thyroid Cancer: Implications for Tumorigenesis and Treatment.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 13, p. 3258, doi. 10.3390/ijms20133258
- By:
- Publication type:
- Article
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 9, p. 2226, doi. 10.3390/ijms20092226
- By:
- Publication type:
- Article
New Insights in Thyroid Cancer and p53 Family Proteins.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 6, p. 1325, doi. 10.3390/ijms18061325
- By:
- Publication type:
- Article
Optimal Response in a Patient With CML Expressing BCR–ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report.
- Published in:
- In Vivo, 2020, v. 34, n. 3, p. 1481, doi. 10.21873/invivo.11933
- By:
- Publication type:
- Article
Targeting BCL-2 as a Therapeutic Strategy for Primary <sup>p210</sup>BCR-ABL1-positive B-ALL Cells.
- Published in:
- In Vivo, 2020, v. 34, n. 2, p. 511, doi. 10.21873/invivo.11802
- By:
- Publication type:
- Article
Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports.
- Published in:
- Hematology Reports, 2023, v. 15, n. 2, p. 317, doi. 10.3390/hematolrep15020033
- By:
- Publication type:
- Article
Uncommon long-term survival in a patient with chronic myeloid leukemia.
- Published in:
- Acta Oncologica, 2009, v. 48, n. 8, p. 1215, doi. 10.3109/02841860903156475
- By:
- Publication type:
- Article
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.669469
- By:
- Publication type:
- Article
Glioblastoma, IDH -Wild Type With FGFR3-TACC3 Fusion: When Morphology May Reliably Predict the Molecular Profile of a Tumor. A Case Report and Literature Review.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.823015
- By:
- Publication type:
- Article
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia.
- Published in:
- Molecular Cancer, 2018, v. 17, p. 1, doi. 10.1186/s12943-018-0805-1
- By:
- Publication type:
- Article
Combined Inhibition of Bcl2 and Bcr-Abl1 Exercises Anti-Leukemia Activity but Does Not Eradicate the Primitive Leukemic Cells.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 23, p. 5606, doi. 10.3390/jcm10235606
- By:
- Publication type:
- Article
Diagnostic Utility of the Immunohistochemical Expression of Serine and Arginine Rich Splicing Factor 1 (SRSF1) in the Differential Diagnosis of Adult Gliomas.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2086, doi. 10.3390/cancers13092086
- By:
- Publication type:
- Article
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.612385
- By:
- Publication type:
- Article
BCR‐ABL residues interacting with Ponatinib are critical to preserve the tumorigenic potential of the oncoprotein (59.6).
- Published in:
- FASEB Journal, 2014, v. 28, p. N.PAG, doi. 10.1096/fasebj.28.1_supplement.59.6
- By:
- Publication type:
- Article
BCR-ABL residues interacting with ponatinib are critical to preserve the tumorigenic potential of the oncoprotein.
- Published in:
- FASEB Journal, 2014, v. 28, n. 3, p. 1221, doi. 10.1096/fj.13-236992
- By:
- Publication type:
- Article
IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation.
- Published in:
- Carcinogenesis, 2014, v. 35, n. 5, p. 1132, doi. 10.1093/carcin/bgu013
- By:
- Publication type:
- Article
Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in Breast Cancer.
- Published in:
- Cancer Genomics & Proteomics (1109-6535), 2022, v. 19, n. 4, p. 464, doi. 10.21873/cgp.20333
- By:
- Publication type:
- Article
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00057
- By:
- Publication type:
- Article
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 5, p. N.PAG, doi. 10.3390/diagnostics12051051
- By:
- Publication type:
- Article
A Case of Non-Irradiated Balloon Cell Melanoma of the Choroid: Expanding the Morphological Spectrum of Primary Uveal Melanomas.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 3, p. 642, doi. 10.3390/diagnostics12030642
- By:
- Publication type:
- Article
A Novel System for Semiautomatic Sample Processing in Chronic Myeloid Leukaemia: Increasing Throughput without Impacting on Molecular Monitoring at Time of SARS-CoV-2 Pandemic.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 8, p. 1502, doi. 10.3390/diagnostics11081502
- By:
- Publication type:
- Article
Multiple primary malignances managed with surgical excision: a case report with next generation sequencing analysis.
- Published in:
- Molecular Biology Reports, 2022, v. 49, n. 9, p. 9059, doi. 10.1007/s11033-022-07630-8
- By:
- Publication type:
- Article
Rapid decline of Philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript: A case report.
- Published in:
- Oncology Letters, 2019, v. 18, n. 3, p. 2648, doi. 10.3892/ol.2019.10558
- By:
- Publication type:
- Article
A Custom DNA-Based NGS Panel for the Molecular Characterization of Patients With Diffuse Gliomas: Diagnostic and Therapeutic Applications.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.861078
- By:
- Publication type:
- Article
Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice.
- Published in:
- Genes, 2019, v. 10, n. 9, p. 709, doi. 10.3390/genes10090709
- By:
- Publication type:
- Article
Colony-Forming Cell Assay Detecting the Co-Expression of JAK2<sup>V617F</sup> and BCR-ABL1 in the Same Clone: A Case Report.
- Published in:
- Acta Haematologica, 2019, v. 141, n. 4, p. 261, doi. 10.1159/000496821
- By:
- Publication type:
- Article
Cerebellar liponeurocytoma: clinical, histopathological and molecular features of a series of three cases, including one recurrent tumor.
- Published in:
- Neuropathology, 2022, v. 42, n. 3, p. 169, doi. 10.1111/neup.12799
- By:
- Publication type:
- Article
High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability.
- Published in:
- OncoTargets & Therapy, 2023, v. 16, p. 803, doi. 10.2147/OTT.S413825
- By:
- Publication type:
- Article